How does PI-RADS v2.1 impact patient classification? A head-to-head comparison between PI-RADS v2.0 and v2.1

Ana Sofia Linhares Moreira1, Pieter De Visschere2, Charles Van Praet3

  • 1Radiology Department, Centro Hospitalar Universitário do Algarve, Faro, Portugal.

Abstract

Insights

The updated Prostate Imaging Reporting and Data System (PI-RADS) v2.1 classification primarily downgraded benign nodules in the transition zone. This change had minimal impact on overall positive prostate MRI detection rates.

Area of Science:

  • Radiology
  • Oncology
  • Urology

Background:

  • The Prostate Imaging Reporting and Data System (PI-RADS) classification for prostate MRI has been updated.
  • The extent of changes introduced by the PI-RADS v2.1 update is not yet fully understood.

Purpose of the Study:

  • To quantify the shifts in PI-RADS categorization between version 2.0 and version 2.1.
  • To evaluate the impact of PI-RADS updates on prostate MRI interpretation.

Main Methods:

  • Retrospective analysis of 535 diagnostic prostate MRI studies.
  • Assigning PI-RADS categories (v2.0 and v2.1) to peripheral zones, transition zones, and the whole gland.
  • Statistical evaluation using the McNemar test to assess significance of category changes.

Main Results:

  • PI-RADS v2.1 showed a notable downgrading of PI-RADS 2 categories to PI-RADS 1, particularly in the transition zone (56.8%).
  • The proportion of PI-RADS 1 significantly increased (0.6% to 7.3%), while PI-RADS 2 significantly decreased (60.0% to 53.8%).
  • No significant change in the overall proportion of positive prostate MRI exams (PI-RADS 3-5) was observed (39.4% vs. 38.8%).

Conclusions:

  • The primary change in PI-RADS v2.1 involves downgrading benign prostatic hyperplasia nodules in the transition zone from category 2 to category 1.
  • The updated PI-RADS classification did not significantly alter the number of positive or negative MRI findings.
  • The clinical management impact of PI-RADS v2.1 is expected to be low.